CCM
TIL icon

CAAS Capital Management’s Instil Bio TIL Stock Holding History

CAAS Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,025
Closed -$1.48M – 1001
2022
Q2 		$1.48M Buy
+16,025
New +$2.27M 0.07% 297
2021
Q2 		– Sell
-3,250
Closed -$1.63M – 1278
2021
Q1 		$1.63M Buy
+3,250
New +$1.67M 0.02% 653

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CAAS Capital Management's TIL Position: Q3 2022 in Review

CAAS Capital Management sold out of Instil Bio (TIL) in Q3 2022, closing a stake of 16,025 shares — an estimated $1.48M sold.

CAAS Capital Management first reported a position in TIL in Q1 2021 and held it in 2 quarters. The position peaked at $1.63M in Q1 2021. 95 funds tracked by Wall St. Rank hold TIL as of Q3 2022.

  • CAAS Capital Management reported no remaining Instil Bio position as of Q3 2022 after selling out during the quarter.
  • CAAS Capital Management sold 16,025 Instil Bio shares in Q3 2022, an estimated $1.48M.
  • CAAS Capital Management first reported a position in Instil Bio in Q1 2021 and held it in 2 quarters.
  • CAAS Capital Management's Instil Bio position peaked at $1.63M in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Instil Bio as of Q3 2022.

Based on CAAS Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.